Novo Nordisk raises adjusted sales and adjusted operating profit outlook for 2026

EarningsPositive

AI Analysis

Summary

Novo Nordisk announced Q2 2026 adjusted sales and operating profit results and raised its full-year 2026 adjusted sales and operating profit guidance.

Financial Highlights

Guidance

raised 2026 full-year adjusted sales and adjusted operating profit outlook

Importance:5/10

Sentiment:

0.60

earningsguidanceQ2_2026full_year_outlook

Related Companies

$NVO

Read the original article

Published by GlobeNewswire Pharma on August 4, 2026 4:33 PM

Read Original